AMICUS THERAPEUTICS INC. - COMMON STOCK

Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates

09 مايو 2024 06:00:01 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference

08 مايو 2024 06:00:01 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024

01 مايو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report

20 مارس 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024

01 مارس 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates

28 فبراير 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024

15 فبراير 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™

08 فبراير 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024

01 فبراير 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook

07 يناير 2024 15:00:52 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 يناير 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics Congratulates Executive Chairman John F. Crowley on Appointment as Next President and CEO of BIO

05 ديسمبر 2023 05:00:38 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate Updates

08 نوفمبر 2023 06:00:01 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2023

01 نوفمبر 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics to Announce Third Quarter 2023 Financial Results on November 8, 2023

27 أكتوبر 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics Announces Presentation and Posters at World Muscle Society 2023

03 أكتوبر 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration

02 أكتوبر 2023 07:20:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe Disease

28 سبتمبر 2023 09:41:45 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2023

01 سبتمبر 2023 06:00:18 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics Announces Presentation and Posters at the SSIEM Annual Symposium 2023

29 أغسطس 2023 06:00:00 بحسب Nasdaq GlobeNewswire